The market was valued at US$ 422.7 Mn in 2022 and is projected to grow at a CAGR of 5.2% from 2023 to 2031, reaching more than US$ 666.5 Mn by 2031. The global biliary stents market is experiencing consistent growth, driven by the rising prevalence of biliary diseases such as bile duct obstruction, gallstones, and pancreatic cancer. Biliary stents play a crucial role in maintaining bile flow from the liver to the intestine, thereby preventing complications such as jaundice and infections. With advancements in minimally invasive procedures and increasing healthcare awareness, the demand for biliary stents is steadily increasing across the globe.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22892

Market Overview

The biliary stents market is an integral part of the broader gastrointestinal and interventional healthcare segment. These medical devices are widely used in endoscopic and percutaneous procedures to treat obstructions in the bile ducts caused by both malignant and benign conditions. The growing aging population, which is more susceptible to such disorders, is a major factor contributing to market expansion. Additionally, improvements in diagnostic techniques and the increasing adoption of endoscopic retrograde cholangiopancreatography (ERCP) procedures are enhancing the effectiveness of biliary stent placement. The shift toward minimally invasive treatments is further supporting market growth, as patients and healthcare providers prefer procedures that offer faster recovery and reduced risks.

Market Size and Growth

The biliary stents market, valued at US$ 422.7 Mn in 2022, is expected to surpass US$ 666.5 Mn by 2031, reflecting a steady CAGR of 5.2%. This growth is supported by the rising incidence of cancers affecting the liver, pancreas, and bile ducts, which often require stenting as part of palliative care. Furthermore, increasing healthcare expenditure and improved access to medical services in emerging economies are contributing to the market’s expansion. Technological advancements, such as the development of self-expanding metal stents and drug-eluting stents, are also enhancing treatment outcomes and driving adoption. The consistent demand for effective and reliable treatment options ensures a stable growth trajectory for the market.

Market Segmentation

The global biliary stents market can be segmented based on product type, material, end-user, and application. By product type, the market includes plastic stents and metal stents, with metal stents gaining popularity due to their longer patency and durability. In terms of material, options include stainless steel, nitinol, and polymer-based stents, each offering specific advantages depending on the clinical scenario. End-users primarily include hospitals, ambulatory surgical centers, and specialty clinics, with hospitals accounting for the largest share due to higher patient volumes and advanced infrastructure. Applications range from malignant biliary obstruction to benign conditions, highlighting the versatility of these devices in clinical practice.

Regional Analysis

Regionally, North America dominates the global biliary stents market, driven by advanced healthcare infrastructure, high awareness levels, and the presence of leading medical device manufacturers. Europe also holds a significant share, supported by well-established healthcare systems and increasing adoption of innovative medical technologies. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, owing to rising healthcare investments, a large patient population, and improving access to medical facilities in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are emerging markets, offering growth opportunities as healthcare infrastructure continues to develop.

Competitive Landscape

The global biliary stents market is moderately competitive, with several key players focusing on innovation, product development, and strategic collaborations to strengthen their market positions. Prominent companies operating in the market include Boston Scientific Corporation, Cook Medical, Olympus Corporation, Medtronic, C. R. Bard (Becton, Dickinson & Company), CONMED Corporation, Merit Medical Systems, Inc., and Cordis Corporation (Cardinal Health). These companies are investing heavily in research and development to introduce advanced stent technologies that improve patient outcomes and reduce complications. Strategic partnerships, mergers, and acquisitions are also common approaches adopted by these players to expand their global footprint.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453